Canada Pension Plan Investment Board’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Buy
87,300
+34,000
+64% +$102K ﹤0.01% 1503
2026
Q1
$164K Buy
53,300
+23,300
+78% +$98.9K ﹤0.01% 1601
2025
Q4
$108K Buy
+30,000
New +$131K ﹤0.01% 1795
2022
Q2
– Sell
-182,000
Closed -$1.11M – 1248
2022
Q1
$1.11M Buy
+182,000
New +$1.34M ﹤0.01% 826
2021
Q4
– Sell
-300,000
Closed -$3.39M – 1441
2021
Q3
$3.39M Buy
+300,000
New +$3.65M ﹤0.01% 749

Other funds holding ALT

Canada Pension Plan Investment Board's ALT Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Altimmune (ALT) stake by 64% in Q2 2026, buying an estimated $102K and bringing the position to 87,300 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Canada Pension Plan Investment Board first reported a position in ALT in Q3 2021 and has held it in 5 quarters since. The position peaked at $3.39M in Q3 2021. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Canada Pension Plan Investment Board held 87,300 shares of Altimmune worth $265K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 34,000 Altimmune shares in Q2 2026, an estimated $102K.
  • Altimmune made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1503 holding.
  • Canada Pension Plan Investment Board first reported a position in Altimmune in Q3 2021 and has held it in 5 quarters since.
  • Canada Pension Plan Investment Board's Altimmune position peaked at $3.39M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.